 Jon Blevins
Concepts (189)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Borrelia burgdorferi | 19 | 2020 | 28 | 5.340 |
Why?
| | Bacterial Proteins | 22 | 2020 | 456 | 3.510 |
Why?
| | Lyme Disease | 11 | 2020 | 28 | 3.190 |
Why?
| | Gene Expression Regulation, Bacterial | 18 | 2020 | 246 | 2.230 |
Why?
| | Adhesins, Bacterial | 5 | 2015 | 30 | 1.060 |
Why?
| | Trans-Activators | 7 | 2009 | 147 | 0.930 |
Why?
| | Lipoproteins | 3 | 2020 | 45 | 0.920 |
Why?
| | Bacterial Outer Membrane Proteins | 6 | 2008 | 32 | 0.850 |
Why?
| | Sigma Factor | 7 | 2016 | 24 | 0.790 |
Why?
| | Mutagenesis | 4 | 2018 | 77 | 0.740 |
Why?
| | Serine Endopeptidases | 2 | 2019 | 57 | 0.740 |
Why?
| | Staphylococcus aureus | 8 | 2019 | 363 | 0.740 |
Why?
| | Borrelia | 1 | 2019 | 1 | 0.720 |
Why?
| | Relapsing Fever | 1 | 2019 | 1 | 0.720 |
Why?
| | Animal Diseases | 1 | 2019 | 3 | 0.720 |
Why?
| | Lac Repressors | 2 | 2018 | 3 | 0.720 |
Why?
| | Virulence Factors | 3 | 2019 | 94 | 0.700 |
Why?
| | Mutation | 8 | 2019 | 1504 | 0.670 |
Why?
| | Genetic Engineering | 1 | 2018 | 27 | 0.630 |
Why?
| | Ixodes | 2 | 2008 | 6 | 0.580 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 462 | 0.550 |
Why?
| | Microbial Viability | 2 | 2019 | 34 | 0.470 |
Why?
| | Lysine | 1 | 2014 | 102 | 0.470 |
Why?
| | Antigens, Bacterial | 4 | 2008 | 63 | 0.460 |
Why?
| | Arachnid Vectors | 2 | 2014 | 4 | 0.450 |
Why?
| | Genes, Essential | 2 | 2012 | 14 | 0.450 |
Why?
| | Mice | 12 | 2020 | 6429 | 0.420 |
Why?
| | Bites and Stings | 2 | 2008 | 21 | 0.380 |
Why?
| | RNA Polymerase Sigma 54 | 5 | 2012 | 6 | 0.370 |
Why?
| | Animals | 15 | 2020 | 14411 | 0.370 |
Why?
| | Needles | 1 | 2008 | 31 | 0.320 |
Why?
| | Mice, Inbred C3H | 5 | 2014 | 82 | 0.310 |
Why?
| | Luciferases | 1 | 2007 | 57 | 0.300 |
Why?
| | Genes, Reporter | 1 | 2007 | 98 | 0.290 |
Why?
| | Staphylococcal Infections | 3 | 2019 | 302 | 0.280 |
Why?
| | Operon | 3 | 2019 | 38 | 0.280 |
Why?
| | DNA Mutational Analysis | 3 | 2016 | 217 | 0.270 |
Why?
| | Repressor Proteins | 1 | 2007 | 165 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 3 | 2020 | 1664 | 0.260 |
Why?
| | Gene Deletion | 4 | 2019 | 293 | 0.240 |
Why?
| | Promoter Regions, Genetic | 5 | 2018 | 520 | 0.240 |
Why?
| | Genetic Complementation Test | 4 | 2014 | 55 | 0.240 |
Why?
| | Genes, Bacterial | 5 | 2018 | 67 | 0.230 |
Why?
| | Musculoskeletal Diseases | 1 | 2003 | 40 | 0.220 |
Why?
| | Arthritis, Infectious | 1 | 2003 | 42 | 0.220 |
Why?
| | Transcription Factors | 3 | 2019 | 622 | 0.210 |
Why?
| | Osteomyelitis | 1 | 2003 | 124 | 0.200 |
Why?
| | Spirochaetales | 1 | 2020 | 2 | 0.200 |
Why?
| | Disease Models, Animal | 4 | 2015 | 1648 | 0.190 |
Why?
| | Ticks | 2 | 2014 | 6 | 0.190 |
Why?
| | Recombinant Proteins | 2 | 2020 | 570 | 0.180 |
Why?
| | Leukocidins | 1 | 2019 | 8 | 0.180 |
Why?
| | Exotoxins | 1 | 2019 | 9 | 0.180 |
Why?
| | Mammals | 1 | 2019 | 59 | 0.180 |
Why?
| | Phagosomes | 1 | 2019 | 21 | 0.180 |
Why?
| | Body Temperature | 1 | 2019 | 83 | 0.170 |
Why?
| | Membrane Proteins | 2 | 2020 | 389 | 0.170 |
Why?
| | DNA, Bacterial | 3 | 2016 | 172 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 26 | 0.170 |
Why?
| | Bacterial Toxins | 1 | 2019 | 61 | 0.170 |
Why?
| | Genetic Vectors | 2 | 2018 | 139 | 0.170 |
Why?
| | Computational Biology | 1 | 2020 | 231 | 0.170 |
Why?
| | Hot Temperature | 1 | 2019 | 199 | 0.160 |
Why?
| | Transformation, Bacterial | 1 | 2018 | 5 | 0.160 |
Why?
| | Electroporation | 1 | 2018 | 17 | 0.160 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 41 | 0.160 |
Why?
| | Crystallography, X-Ray | 3 | 2014 | 178 | 0.150 |
Why?
| | Stress, Physiological | 1 | 2019 | 194 | 0.150 |
Why?
| | Up-Regulation | 2 | 2018 | 509 | 0.150 |
Why?
| | Treponema pallidum | 2 | 2007 | 10 | 0.150 |
Why?
| | Proteomics | 1 | 2019 | 343 | 0.140 |
Why?
| | Rats | 2 | 2020 | 3419 | 0.140 |
Why?
| | Biofilms | 3 | 2015 | 202 | 0.130 |
Why?
| | DNA Replication | 1 | 2016 | 152 | 0.130 |
Why?
| | Protein Kinases | 1 | 2015 | 88 | 0.120 |
Why?
| | Point Mutation | 1 | 2014 | 92 | 0.120 |
Why?
| | Mutant Proteins | 1 | 2014 | 41 | 0.120 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 105 | 0.120 |
Why?
| | Immune Evasion | 1 | 2014 | 12 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2019 | 958 | 0.120 |
Why?
| | Protein Conformation | 1 | 2014 | 226 | 0.120 |
Why?
| | Female | 6 | 2020 | 28474 | 0.120 |
Why?
| | Plasmids | 3 | 2008 | 180 | 0.110 |
Why?
| | Molecular Sequence Data | 4 | 2007 | 980 | 0.110 |
Why?
| | RNA, Bacterial | 4 | 2008 | 58 | 0.110 |
Why?
| | Protein Binding | 3 | 2009 | 736 | 0.100 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2009 | 74 | 0.100 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1141 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2010 | 5 | 0.090 |
Why?
| | Transcription, Genetic | 4 | 2008 | 418 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 50 | 0.090 |
Why?
| | Bacterial Vaccines | 1 | 2008 | 16 | 0.080 |
Why?
| | Antigens, Surface | 1 | 2008 | 55 | 0.080 |
Why?
| | Injections, Intradermal | 1 | 2008 | 15 | 0.080 |
Why?
| | Periplasmic Binding Proteins | 1 | 2007 | 3 | 0.080 |
Why?
| | Polyamines | 1 | 2007 | 10 | 0.080 |
Why?
| | Isopropyl Thiogalactoside | 1 | 2007 | 1 | 0.080 |
Why?
| | Fireflies | 1 | 2007 | 1 | 0.080 |
Why?
| | Genetic Techniques | 1 | 2007 | 15 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 674 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 274 | 0.070 |
Why?
| | Humans | 6 | 2019 | 54397 | 0.070 |
Why?
| | Virulence | 2 | 2005 | 196 | 0.070 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2005 | 25 | 0.070 |
Why?
| | Carbon-Sulfur Lyases | 1 | 2004 | 2 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2004 | 60 | 0.060 |
Why?
| | Phosphorylation | 2 | 2016 | 613 | 0.060 |
Why?
| | Colony Count, Microbial | 2 | 2019 | 66 | 0.060 |
Why?
| | Adaptation, Physiological | 2 | 2019 | 103 | 0.060 |
Why?
| | RNA, Antisense | 1 | 2002 | 10 | 0.050 |
Why?
| | Immunoblotting | 2 | 2015 | 134 | 0.050 |
Why?
| | Lipase | 1 | 2002 | 18 | 0.050 |
Why?
| | Hemolysin Proteins | 1 | 2002 | 17 | 0.050 |
Why?
| | Hemolysis | 1 | 2002 | 32 | 0.050 |
Why?
| | Fibronectins | 1 | 2002 | 41 | 0.050 |
Why?
| | Collagen | 1 | 2002 | 223 | 0.050 |
Why?
| | Binding Sites | 3 | 2006 | 440 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2015 | 370 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2002 | 360 | 0.040 |
Why?
| | Base Sequence | 3 | 2006 | 719 | 0.040 |
Why?
| | Incidence | 1 | 2003 | 1084 | 0.040 |
Why?
| | Guanosine Pentaphosphate | 1 | 2019 | 1 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2019 | 1 | 0.040 |
Why?
| | Regulon | 1 | 2019 | 11 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2003 | 1082 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2019 | 85 | 0.040 |
Why?
| | Culture Media | 1 | 2019 | 100 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 825 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2008 | 194 | 0.040 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 289 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2015 | 18 | 0.030 |
Why?
| | Lung | 1 | 2019 | 508 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 2006 | 198 | 0.030 |
Why?
| | DNA Primers | 2 | 2006 | 225 | 0.030 |
Why?
| | Models, Molecular | 2 | 2007 | 423 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 125 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 206 | 0.030 |
Why?
| | Ligands | 2 | 2006 | 229 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2008 | 1203 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 57 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 48 | 0.020 |
Why?
| | Cell Separation | 1 | 2010 | 107 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2010 | 197 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2008 | 5 | 0.020 |
Why?
| | Myxococcus xanthus | 1 | 2008 | 1 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 145 | 0.020 |
Why?
| | Time Factors | 2 | 2006 | 3210 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 180 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2010 | 658 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 177 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 547 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2010 | 720 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2006 | 117 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 474 | 0.020 |
Why?
| | Calorimetry | 1 | 2006 | 9 | 0.020 |
Why?
| | Nucleosides | 1 | 2006 | 5 | 0.020 |
Why?
| | Histidine | 1 | 2006 | 17 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2006 | 55 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 99 | 0.020 |
Why?
| | Models, Chemical | 1 | 2006 | 65 | 0.020 |
Why?
| | Restriction Mapping | 1 | 2005 | 32 | 0.020 |
Why?
| | Purines | 1 | 2006 | 45 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 2 | 0.020 |
Why?
| | Biological Transport | 1 | 2006 | 195 | 0.020 |
Why?
| | Cytoplasm | 1 | 2006 | 109 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2005 | 99 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 425 | 0.020 |
Why?
| | Ethidium | 1 | 2004 | 7 | 0.020 |
Why?
| | Plankton | 1 | 2004 | 5 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2005 | 69 | 0.020 |
Why?
| | RNA | 1 | 2006 | 202 | 0.020 |
Why?
| | Ciprofloxacin | 1 | 2004 | 28 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2006 | 242 | 0.020 |
Why?
| | Anaerobiosis | 1 | 2004 | 15 | 0.020 |
Why?
| | Cell Membrane | 1 | 2006 | 279 | 0.020 |
Why?
| | Models, Genetic | 1 | 2005 | 209 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2005 | 100 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 198 | 0.020 |
Why?
| | Kinetics | 1 | 2006 | 692 | 0.020 |
Why?
| | Escherichia coli | 1 | 2006 | 250 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2003 | 25 | 0.010 |
Why?
| | Vancomycin | 1 | 2004 | 88 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 108 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 531 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 64 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2003 | 76 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 388 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 376 | 0.010 |
Why?
| | Male | 1 | 2003 | 27348 | 0.010 |
Why?
|
|
Blevins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|